Document Detail


Calcium-stimulated adenylyl cyclases modulate ethanol-induced neurodegeneration in the neonatal brain.
MedLine Citation:
PMID:  15745964     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Fetal alcohol exposure results in cognitive and neurobehavioral deficits, but the effects of modifying genetic loci on the severity of these sequelas have not been well characterized. Although the cAMP signaling pathway has been shown to be an important modulator of ethanol sensitivity in adult mice, its potential role in modulating ethanol-induced neurodegeneration has not been examined. Adenylyl cyclases (ACs) 1 and 8 produce cAMP in response to intracellular calcium elevation and modulate several aspects of neuronal function, including ethanol sensitivity. AC1 and AC8 are expressed widely throughout the brain of neonatal mice, and genetic deletion of both AC1 and AC8 in double-knock-out (DKO) mice enhances ethanol-induced neurodegeneration in the brains of neonatal mice. In addition, ethanol treatment induces significantly greater levels of caspase-3 activation in the brains of DKO mice compared with wild-type (WT) mice, reflecting higher numbers of apoptotic neurons. Administration of the NMDA receptor antagonist MK801 [(+)-5-methyl-10,11-dihydro-5H-dibenzo [a,d] cyclohepten-5,10-imine hydrogen maleate] or the GABA(A) receptor potentiator phenobarbital, which mimics components of the effects of ethanol on neurons, results in significantly greater neurodegeneration in the brains of neonatal DKO mice than WT mice. Furthermore, loss of a single calcium-stimulated AC isoform potentiates neurodegeneration after administration of ethanol, MK801, or phenobarbital. In contrast, the levels of physiological cell death, death after hypoxia/ischemia, and excitotoxic cell death are not increased in the brains of DKO mice. Thus, AC1 and AC8 are critical modulators of neurodegeneration induced by activity blockade in the neonatal brain and represent genetic loci that may potentially modify the severity of fetal alcohol syndrome.
Authors:
James W Maas; Ricardo A Indacochea; Lisa M Muglia; Timothy T Tran; Sherri K Vogt; Tim West; Ann Benz; Amanda A Shute; David M Holtzman; Steven Mennerick; John W Olney; Louis J Muglia
Related Documents :
8485854 - Developmental changes in seizure susceptibility in carbonic anhydrase ii-deficient mice...
4474904 - Effects of catecholamine synthesis inhibition on ethanol-induced withdrawal symptoms in...
8561294 - Alcohol ingestion impairs host defenses predisposing otherwise healthy mice to pneumocy...
2906594 - Metabolism of the prodrug dega (n-(2,6-dimethylphenyl)-4-[[(diethylamino)acetyl]amino]b...
16309674 - Molecular and synaptic changes in the hippocampus underlying superior spatial abilities...
21724994 - The inhibiting fc receptor for igg, fcγriib, is a modifier of autoimmune susceptibility.
Publication Detail:
Type:  Comparative Study; In Vitro; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  The Journal of neuroscience : the official journal of the Society for Neuroscience     Volume:  25     ISSN:  1529-2401     ISO Abbreviation:  J. Neurosci.     Publication Date:  2005 Mar 
Date Detail:
Created Date:  2005-03-04     Completed Date:  2006-03-31     Revised Date:  2009-09-03    
Medline Journal Info:
Nlm Unique ID:  8102140     Medline TA:  J Neurosci     Country:  United States    
Other Details:
Languages:  eng     Pagination:  2376-85     Citation Subset:  IM    
Affiliation:
Department of Pediatrics, Washington University School of Medicine, St. Louis, Missouri 63110, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adenylate Cyclase / metabolism*
Anilides / metabolism
Animals
Animals, Newborn
Anoxia / metabolism,  pathology
Behavior, Animal
Blotting, Western / methods
Brain / drug effects*,  growth & development,  pathology
Calcium / pharmacology*
Caspase 3
Caspases / metabolism
Dizocilpine Maleate / pharmacology
Dose-Response Relationship, Drug
Drug Interactions
Ethanol* / blood
GABA Modulators / pharmacology
Hippocampus / drug effects,  metabolism,  pathology,  physiopathology
In Situ Hybridization / methods
Mice
Mice, Inbred C57BL
Neurodegenerative Diseases / chemically induced*,  drug therapy,  metabolism,  pathology
Neurons / metabolism,  physiology
Neuroprotective Agents / pharmacology
Oligopeptides / metabolism
Phenobarbital / pharmacology
Silver Staining / methods
Time Factors
Grant Support
ID/Acronym/Agency:
AA12952/AA/NIAAA NIH HHS; AA12957/AA/NIAAA NIH HHS; AG18876/AG/NIA NIH HHS
Chemical
Reg. No./Substance:
0/Anilides; 0/GABA Modulators; 0/Neuroprotective Agents; 0/Oligopeptides; 0/aspartyl-glutamyl-valyl-aspartyl-p-nitroanilide; 50-06-6/Phenobarbital; 64-17-5/Ethanol; 7440-70-2/Calcium; 77086-22-7/Dizocilpine Maleate; EC 3.4.22.-/Casp3 protein, mouse; EC 3.4.22.-/Caspase 3; EC 3.4.22.-/Caspases; EC 4.6.1.1/Adenylate Cyclase; EC 4.6.1.1/adenylyl cyclase 1

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Endothelial nitric oxide synthase regulates brain-derived neurotrophic factor expression and neuroge...
Next Document:  Axonal transport, amyloid precursor protein, kinesin-1, and the processing apparatus: revisited.